MB2 Dental on a $2.344 billion unitranche debt facility with credit vehicles and accounts managed by KKR.
Peak Rock Capital in its sale of Paragon Healthcare, Inc., a leading provider of infusion and other specialty pharmacy services, to Elevance Health, Inc.
Rite Aid Corporation (“Rite Aid”) and 119 of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey.
Eli Lilly in its $1.4 billion acquisition of POINT Biopharma Global Inc.
Thoma Bravo, a leading software investment firm, in its acquisition of Bluesight, the Medication Intelligence™ Company.
Thoma Bravo in Bluesight’s acquisition of Medacist, a pioneer in drug diversion monitoring VSP Vision on acquisition of Professional Eye Care Associates of America.
HGGC in its acquisition of Dentive, LLC, a dental services organization.
TPG Growth, LLC in its partnership with Novant Health to expand MedQuest Associates.
Oak Street Health (NYSE: OSH) in its $10.6 billion sale to CVS Health (NYSE: CVS).
VSP Vision in its acquisition of Professional Eye Care Associates of America.
Thoma Bravo in its strategic growth investment in Circle Cardiovascular Imaging, the global leader in cardiovascular imaging solutions.
Maravai LifeSciences, Inc. in its acquisition of MyChem, LLC.
Gryphon Investors in its acquisition of Metagenics.
One Equity Partners in its investment in Infucare RX.
Clayton, Dubilier & Rice, LLC in its investment in Vera Whole Health.
Incline Equity Partners in its investment in Revival Animal Health.
Vestar Capital Partners in its investment in Friday Health Plans.
Vitruvian Partners in its acquisition of a majority stake in KCAS Bioanalytical and Biomarker Services, an Integris Bioservices, LLC company.
Carlyle Group in its diversture of Newport Academy.
Vista Equity Partners in its investment in iN2L.
